BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9854168)

  • 1. A specific cutaneous lesion revealing myelodysplastic syndrome.
    Kajisawa C; Matsui C; Morohashi M
    Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphnode localization of extramedullary myeloid cell tumor in myelodysplastic syndrome: report of one case diagnosed by fine-needle cytology.
    Fulciniti F; Zeppa P; Marino G; Martinelli V; Ciancia R; Del Vecchio L; Rotoli B; Palombini L
    Diagn Cytopathol; 2003 Mar; 28(3):136-9. PubMed ID: 12619094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual specific cutaneous lesions in myelodysplastic syndromes.
    Aractingi S; Bachmeyer C; Miclea JM; Vérola O; Rousselot P; Dubertret L; Daniel MT
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):187-91. PubMed ID: 7622643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of myelodysplastic syndrome and multiple myeloma.
    Tsiara S; Economou G; Panteli A; Isaakidis P; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 1999 Dec; 18(4):565-6. PubMed ID: 10746986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
    Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
    Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
    Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful induction chemotherapy for childhood RAEB-T with VP-16: a case report].
    Tanizawa A; Sonomura T; Wakazono Y; Akiyama Y; Kubota M; Mikawa H
    Rinsho Ketsueki; 1989 Jul; 30(7):1052-7. PubMed ID: 2810790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?
    Ohyashiki K; Yokoyama K; Kimura Y; Ohyashiki JH; Ito T; Kuratsuji T; Komatsumoto S; Nara M; Toyama K
    Leukemia; 1993 Feb; 7(2):338-40. PubMed ID: 8426488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atypical infiltration of megakaryocytes into the liver and spleen in a case of refractory anemia].
    Sato K; Ushijima T; Ohbayashi Y; Sato H; Urabe A
    Rinsho Ketsueki; 1990 Jul; 31(7):1004-7. PubMed ID: 2214179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
    Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
    Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sweet's syndrome associated with myelodysplastic syndrome].
    Furukawa Y; Inoue T; Yamane T; Hiyoshi M; Sasaki A; Kishida T; Kojima K; Im T; Tatsumi N
    Rinsho Ketsueki; 1989 May; 30(5):764-7. PubMed ID: 2795888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isochromosome 17q as the sole alteration in 2 patients with a myelodysplastic syndrome and its relation to myeloperoxidase activity].
    Solé F; Pérez A; Woessner S; Olmedo E; Florensa L; Sans J
    Sangre (Barc); 1991 Aug; 36(4):323-5. PubMed ID: 1663663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical cutaneous myeloid infiltrate in myelodysplastic syndrome: a case report.
    Kwan JM; Trafeli JP; DeRienzo D
    Cutis; 2007 Sep; 80(3):223-8. PubMed ID: 17956012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
    Perez A; Kennedy C; Standen G; Oxley J
    Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete remission of MDS RAEB following immunosuppressive treatment in a patient with Sweet's syndrome.
    Ten Oever J; Kuijper PH; Kuijpers AL; Dercksen MW; Vreugdenhil G
    Neth J Med; 2009 Sep; 67(8):347-50. PubMed ID: 19767665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Appearance of Sweet's syndrome in a patient with myelodysplastic syndrome (MDS) without relation to the hematological findings of MDS].
    Hasegawa Y; Tomiyama J; Ninomiya H; Abe T
    Rinsho Ketsueki; 1989 Jun; 30(6):863-7. PubMed ID: 2795896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts.
    Koca E; Buyukasik Y; Cetiner D; Yilmaz R; Sayinalp N; Yasavul U; Uner A
    Leuk Res; 2008 Mar; 32(3):495-9. PubMed ID: 17706281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].
    Matsuda A; Kusumoto S; Ito K; Yokoo H; Maruyama T; Jinnai I; Harano T; Watanabe K; Hirashima K
    Rinsho Ketsueki; 1996 Jan; 37(1):60-4. PubMed ID: 8683869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative evaluation of juxtatrabecular fibrosis in myelodysplastic syndromes].
    Reissenweber N; Gualco G; Panuncio A; Díaz G
    Sangre (Barc); 1995 Dec; 40(6):479-83. PubMed ID: 8850231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.